Authors : Versha Rajput; Sakshi Bisht

Volume/Issue : Volume 9 - 2024, Issue 10 - October

Google Scholar : https://tinyurl.com/v2tb7zh3

Scribd : https://tinyurl.com/bdpvddw3

DOI : https://doi.org/10.38124/ijisrt/IJISRT24OCT1131

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : The purpose of this manuscript is to provide a thorough overview of current concepts regarding the evaluation and management of diabetic foot infections. One of the most serious and frequent complications that patients with diabetes mellitus come across is diabetic foot infections. A comprehensive investigation of the literature on diabetic foot infections has been conducted, with a focus on the Diabetes mellitus, pathophysiology, identifiable risk factors, evaluation (including physical examination and laboratory values), treatment approaches, and determining the infection's severity. Preventing severe limb loss and maintaining function are the goals of treating diabetic foot infections. Most diabetic foot infections are caused by polymicrobial organisms. It is probable that a variety of gram-positive and gram-negative aerobes are present at the infection site. Controlling the infection and avoiding more morbidity requires early lesion detection, timely initiation of the proper antibiotic therapy, and surgical excision of necrotic tissue and bone.

Keywords : Diabetes Mellitus, Pathophysiology, Risk Factors, Diagnosis, Treatment, Prevention.

References :

[1]. Amjad SS, Zafar J, Shams N. Bacteriology of
diabetic foot in tertiary care hospital; Frequency ,
Antibiotic susceptibility and risk factors. National lib
med. 2017; 29(2):234-240.
[2]. Mathews MS. Antibiotic resistance patterns in
diabetic foot infections. Indian J Med Res.
2017;145(6):863–72.
[3]. Pradeepa R, Mohan V. Epidemiology of type 2
diabetes in India. Indian J Opthalmol. 2021; 69(11):
2932-2938.
[4]. Van Netten JJ, Price PE, Lavery LA, Monteiro-
Soares M, Rasmussen A, Jubiz Y, et al. Prevention of
foot ulcers in the at-risk patient with diabetes: a
systematic review. Diabetes Metab Res Rev.
2016;32(Suppl 1):84–98.
[5]. Rayate SA, Nagoba BS, Mumbre SS, Mavani BH,
Gvkare AM, Deshpanda AS. Current scenario of
traditional medicines in management of diabetic foot
ulcers: A review. World J Daibetes. 2023; 14(1):1-
16.

[6]. Kirketerp-Møller K, Jensen PØ, Fazli M, Madsen
KG, Pedersen J, Moser C, et al. Distribution,
organization, and ecology of bacteria in chronic
wounds. J Clin Microbiol. 2017;46(8):2715–22.
[7]. Lipsky BA, Tabak YP, Johannes RS, Vo L, Hyde L,
Weigelt JA. Skin and soft tissue infections in
hospitalized patients with diabetes: culture isolates
and risk factors associated with mortality, length of
stay, and cost. Diabetologia. 2014;57(9):1826–31.
[8]. Bernard L, Vaudaux P, Stern R, Zanetti G. Trends in
the microbiology of diabetic foot infections. Eur J
Clin Microbiol Infect Dis. 2015;34(3):413–21.
[9]. Zubair M, Malik A, Ahmad J. Clinico-bacteriology
and risk factors for the diabetic foot infection with
multidrug-resistant microorganisms in North India.
Biol Med Res Int. 2019;2019:7135683.
[10]. Lipsky BA, Dryden M, Gottrup F, Nathwani D,
Seaton RA. Managing foot infections in diabetes: A
review of the evidence and expert opinion. Expert
Rev Anti Infect Ther. 2016;14(1):63–74.
[11]. Turzanska K, Adesanya O, Rajagopal A, Pryce MT,
Hughes DF. Improving the Management and
Treatment of Diabetic Foot Infection: Challenges and
Research Opportunities. Int. J. Mol. Sci. 2023;24:1-
16.
[12]. Van Acker K, Oleen-Burkey M, De Moor G,
Willekens K, Lambert J, Martens M, et al. Real-
world outcomes in patients with diabetic foot
infections treated with dalbavancin. Diabet Med.
2019;36(5):635–42.
[13]. Mendicino RW, Pereira H, Laborde J, Frykberg R.
Diabetic foot infections: pharmacologic
interventions. Clin Podiatr Med Surg.
2019;36(2):199–216.
[14]. Thomas Z , Bhurchandi SK et al. Diabetic foot
ulcers, their characteristics, and trends in survival:

Real world outcomes at a tertiary care facility in
India. Sci Direct. 2024; 18(4): 1-8.
[15]. Amin N, Doupis J. Diabetic foot disease: from the
evaluation of the ‘foot at risk’ to the novel diabetic
ulcer treatment modalities. World J Diabetes.
2016;7(7):153.
[16]. Foster AV, Green AD. Foot ulceration and
amputations. Diabet Med. 2017;34(6):742–9.
[17]. Amjad SS, Zafar J, Shams N. Bacteriology of
diabetic foot in tertiary care hospital; Frequency ,
Antibiotic susceptibility and risk factors. National
library of med. 2017; 29(2):234-240.
[18]. Khamaisi M, Hayek T, Kaplan M. Vascular
involvement in diabetic foot infections. Diabetes
Care. 2022;45(2):393–400.
[19]. Noor S, Zubair M, Ahmad J. Diabetic foot ulcer--A
review on pathophysiology, classification and
microbial etiology. Diabetes Metab Syndr. 2015;
9(3): 192-199.
[20]. Nagaya R, Darshini P, Deva R, Jagadeesh R,
Emmanuel P, Narayan G. Optimizing Antibiotic
Treatmentfor Diabetic FootInfections: A Study From
a Tertiary PublicHealthcare Center in Puducherry,
South India. Cureus e60139. 2024; 16(5):1-14.
[21]. Sugandhi P and Prasanth D A. Bacteriological Profile
of diabetic foot infections. Int J innovative Res Sci
Eng Tech 2014;3(7):14688-14692.
[22]. Lavery LA, Hunt NA, Ndosi M. Role of peripheral
neuropathy in diabetic foot infection prognosis. J
Wound Care. 2023;32(1):12–8.
[23]. Bjornsdottir S., Gottfredsson M., Thorisdottir
AS.,Gunnarsson GB, ikardsdottir H, Kristjansson M
et al. Risk factor for acute cellulitis of the lower limb:
a prospective case-control study.Clin Infect Dis
2005; 41(10):1416-22.
[24]. Kathirvel M, Prabhakaran V et al. Risk factors for the
diabetic foot infection with multidrug-resistant
microorganisms in South India. Int Surg J. 2018;
5(2): 675-682.
[25]. Boulton AJM. Peripheral neuropathy and the diabetic
foot. The foot. 1992;2(2):67-72.
[26]. Thomas Z , Bhurchandi SK et al. Diabetic foot
ulcers, their characteristics, and trends in survival:
Real world outcomes at a tertiary care facility in
India. Sci Direct. 2024; 18(4): 1-8.
[27]. Kumar A, Suman et al. Clinical Profile and Outcome
in Patients of Diabetic Foot Infection. Int J App
Basic Med Resear. 2019; 9(1): 1-14.
[28]. Rastogi A, Bhansali A. Diabetic Foot Infection: An
Indian Scenario. J Foot Ankle Surg. 2016; 3(2): 71-
79.
[29]. Van Battum P, Schaper N, Prompers L, Apelqvist J,
Jude E, Piaggesi A et al. differences in minor
amputation rate in diabetic foot disease throughout
Europe are in part explained by differences in disease
severity at presentation. Diabet Med 2011;28(2):199-
205.
[30]. Rastogi A, Sukumar S et al. The microbiology of
diabetic foot infections in patients recently treated
with antibiotic therapy: A prospective study from
India. Nation Lib Med. 2017; 31(2): 407-412.

[31]. Hatipoglu M, Mutluoglu M, Lipsky BA. Diabetic
foot infections: clinical presentation, microbiological
spectrum, and antibiotic resistance. Eur J Clin
Microbiol Infect Dis. 2014;33(6):947–53.
[32]. Flynn MD, Tooke JE. Diabetic neuropathy and the
microcirculation. Diabet Med. 1995; 12(4):298-301.
[33]. Gadepalli R, Dhawan B, Kapil A, Ammini AC,
Chaudhry R. A clinico-microbiological study of
diabetic foot ulcers in an Indian tertiary care hospital.
Diabet Med. 2017;23(3):291–4.
[34]. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters
EJ, Armstrong DG, et al. 2012 Infectious Diseases
Society of America clinical practice guideline for the
diagnosis and treatment of diabetic foot infections.
Clin Infect Dis. 2012;54(12)
[35]. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons
GW, Karchmer AW. Assessment and management of
foot disease in patients with diabetes. N Engl J Med.
1994;3(1):854-60.
[36]. Verma M, Sharma N, Rashi, Arora V. Diabetic Foot
Care Knowledge and Practices in Rural North India:
Insights for Preventive Podiatry. J Assoc Phys Ind.
2021; 69(2):30-34
[37]. Purewal TS, Goss DE, Watkins PJ, Edmonds ME.
Abnormal digital pressure measurements in diabetic
neuropathic foot ulceration. Diabetes Care. 1995;
18(3): 377-381.
[38]. Van Acker K, Oleen-Burkey M, De Moor G,
Willekens K, Lambert J, Martens M, et al. Real-
world outcomes in patients with diabetic foot
infections treated with dalbavancin. Diabet Med.
2019;36(5):635–42.
[39]. Faris I. Mechanisms for the development of foot
lesions. In Farisl ed. The management of the diabetic
foot. 2 a ed. Edimburgo:Churchill Livingstone.
1991:5-8.
[40]. Alharbi, Obaid M, Sulaiman, Abdalrhaim A. Foot
care knowledge, attitude and practices of diabetic
patients: A survey in Diabetes health care facility. J
Fam Med Pri Care. 2022; 11(7): 3816-3823.
[41]. Stevens CM, Glatt AE. MRSA in diabetic foot
infections: a clinical review. Infect Dis Clin North
Am. 2016;30(1):151–63.
[42]. Yadav C, Srikanthia RM, Manjrekar P, Chaudhury
D, Shenoy MT. Assessment of Mineral
Pathophysiology in Patients with Diabetic Foot
Ulcer. Int J Hemat. 2020; 195: 366-372.t Ulce
[43]. Venkatesh M, Kirubakaran V, Nandhini U,
Soundarya M. Rapid diagnostics in diabetic foot
infections. Diabet Med. 2018;35(1):33–40.
[44]. Kandati J., Pathpati R.M., Buchineni M., Sateesh S.,
Premanadam N., Microbiological Profile of Diabetic
Foot Infection In a Tertiary Care Hospital in South
India- A prospective Study.Int J Sci App Res
2015;2(1):64-70.r
[45]. Sethi A, Attri A k, Katariya H, Kochhar S Seth A,
Gautam N et al. Clinical profile and outcome in
patients of Diabetic foot infections. Int J App Basic
Med 2019;9(1):14-19.
[46]. O'Meara S, Nelson EA, Golder S, Dalton JE, Craig
D, Iglesias C;DASIDU Steering Group. Systematic

review of methods to diagnose infection in foot
ulcers in diabetes. Diabet Med. 2006;23(4):341-7.
[47]. Anvarinejad M, Pouladfar G, Japon A, Bolandparvaz
S, Satiary Z and Abbas P et al. Isolation and
antibiotic susceptibility of the microorganisms
isolated from diabetic foot infections in Nemazee
Hospital, Southern Iran. J Pathog 2015;2015:328796.
[48]. Lipsky BA, Senneville E, Abbas ZG, Aragón-
Sánchez J, Diggle M, Embil J, et al. Guidelines on
the diagnosis and treatment of diabetic foot infection
(IWGDF 2019 update). Diabetes Metab Res Rev.
2020;36(S1)
[49]. Singh N, Armstrong DG, Lipsky BA. Preventing foot
ulcers in patients with diabetes. JAMA.
2016;316(1):79–91.
[50]. Jennings PE, Barnett AH. New approaches to the
pathogenesis and treatment of diabetic
microneuropathy. Diabetic Med 1988;5(2):111-117.
[51]. International Working Group on the Diabetic Foot.
IWGDF Guidelines on the prevention and
management of diabetic foot disease. 2019 [cited
2024 Mar 28]. Available from:
https://iwgdfguidelines.org/guidelines/guidelines
[52]. Singh N, Armstrong DG, Lipsky BA. Preventing foot
ulcers in patients with diabetes. J American Med
Assoc. 2005; 293(2): 217-218.
[53]. Mensa J, Barberan J, Llinares P, Picazo JJ, Bouza E,
Alvarez L F et al. Antibiotic multiresistance in
critical care units. medicina intensive 2008;
21(1):234-58.